Twitter Talk: Ayushmann Khurrana's 'Doctor G' Gets Thumbs Up Against Parineeti Chopra's 'Code Name: Tiranga'

Click Here To Promote Anything On The Above Place

Mumbai, October 14 - Ayushmann Khurrana's campus comedy-drama film Doctor G has been released in theaters today along with Parineeti Chopra and Harrdy Sandhu's spy action thriller Code Name: Tiranga and a few other films.

Going by the initial reaction from the movie-goers and critics, it seems "Doctor G" will be the first choice of the audience over the weekend along with the Kannada movie Kantara, of which the Hindi version has been released today after creating waves in Kannada.



Directed by Anubhuti Kashyap in her directorial debut, "Doctor G" is being called hilarious while dealing with a complicated subject where Ayushmann plays a gynecologist. Social comedy-drama has always been Ayushmann's strong zone and it looks like he is back in that after a couple of missed opportunities.

Apart from Ayushmann, the performances of Rakul Preet Sigh, Shefali Shah, and Sheeba Chaddha are getting big recognition. The direction of the movie is also being praised. The only debatable point of the movie, as per the critics' talks, is the second half where the plot of the movie gets off-track, but overall, the film is getting a very good reception.

"Code Name: Tiranga", directed by Ribhu Dasgupta, is a spy action thriller but the initial response is average to the movie. The movie had created a decent buzz through teaser/trailer, but the critics are calling it a failed attampt in this genre. The performence Parineeti Chopra along with other actors is praiseworthy but the direction by Ribhu Dasgupta is being criticised. The movie is being called a low to average affair, which might make it tough for it going forward.

On other other hand, "Kantara" Hindi has recieved super positive reviews from critics and it will give a tough fight to "Doctor G", and other movies. This Rishab Shetty-starrer has potential to outshine all other Hindi movies to take lead going forward, which remains to see.

Stay tuned...